VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AGL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AGLAgilon Health, Inc.
$115.20$1.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
AGL logo

Agilon Health, Inc.

AGL
NYSE · Healthcare Providers
$115.20
At close - Nov 17, 4:00 PM EST - USD
Market Cap$1.92B
P/E-19.2x
52W High$133.04
Volume211.2K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q3

Thin Margin Recovery Faces Persistent Equity and Cash Volatility

Agilon Health's revenue has held in a $1.4B to $1.6B band across the ten quarters shown, and the latest quarter shows a 6.4% gross margin and a 1.6% operating margin, which suggests early operational improvement but not yet durable unit economics.

GrowthMixed
ProfitabilityNegative
ValuationReview
TechnicalsMixed
Explore valuation models
MARKET ACTION

AGL price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

5/12 Beats

EPS beat 5 of last 12 quarters

02

Valuation risk

-158% Peers

P/E is 158% below peer median

03

Market leadership

RS 99 · Leader

High momentum (Outperforming 99% of market)

04

Mixed Trend

Mixed

Price < 50DMA but > 200DMA

Next CatalystEstimated earnings · Feb 4

Market performance

Price History →

Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
AGL+584.09%
S&P 500 (^GSPC)+7.21%
1-Year Return
AGL+757.78%
S&P 500 (^GSPC)+10.03%
3-Year Return
AGL-61.41%
S&P 500 (^GSPC)+60.37%
5-Year Return
AGL-81.78%
S&P 500 (^GSPC)+54.98%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E
-15.1x
Forward P/E
N/A
EV/EBITDA
N/A
FCF YieldCash Flow
N/A

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
-15.1x
N/A
N/A
EV/EBITDA
N/A
N/A
N/A
Price/FCF
N/A
N/A
N/A
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$7.07-93.9%
Base (Fair)$83.10-28.2%
Bull$16.02-86.1%
$7.07 Bear$83.10 Base$16.02 Bull
Current Market Price: $115.20
Trades at a 38.6% premium to Base DCF ($83.10)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$5.93B-2.1% YoY
Net income FY25
-$405M-55.8% YoY
Free cash flow FY25
-$119M-67.5% YoY
Operating margin FY25
-7.1%-2.3 pts YoY
ROIC (FY25)-203.2%
Avg ROIC 5Y-118.1%
ROE (TTM)-51.9%
Piotroski Score2 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate5/12 (42%)
Revenue Beat Rate8/12 (67%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 4, 2026
$1.97+260.2%
vs -$1.23
$1.5B+4.0%
vs $1.5B
Q3 2026
Aug 5, 2026
$1.04+622.2%
vs $0.14
$1.5B+3.0%
vs $1.5B
Q2 2026
May 6, 2026
$1.80+59.3%
vs $1.13
$1.4B+2.9%
vs $1.4B
Q1 2026
Feb 25, 2026
-$11.50-70.4%
vs -$6.75
$1.6B+6.8%
vs $1.5B
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Business Wire·Nov 5, 2026
agilon health to Host Virtual Investor Event “Driving Performance At Scale: The agilon Framework” on November 17, 2026

WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will host a virtual investor event on Tuesday, November 17, 2026, at 2:00 PM ET. The event will feature Dr. Karthik Rao, chief medical officer; Varun Anand, interim chief technology officer; Heidi Hittner, chief business operations officer; and Dr. Jon Copeland, an agilon physician partner from United Physicians. The.

MarketBeat·Nov 5, 2026
Agilon Health Q3 Earnings Call Highlights

Agilon Health NYSE: AGL raised its full-year 2026 outlook after reporting third-quarter results that exceeded its guidance, driven by higher risk-adjustment revenue, clinical program performance and favorable medical cost development in the first half of the year.

Zacks Investment Research·Nov 4, 2026
Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key Metrics

The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research·Nov 4, 2026
Agilon Health (AGL) Q3 Earnings and Revenues Surpass Estimates

Agilon Health (AGL) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of a loss of $2.01 per share. This compares to a loss of $6.75 per share a year ago.

Filtered for Agilon Health, Inc.More Headlines
04

Compare before deciding

Benchmark AGL against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Agilon Health, Inc. (AGL)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
AGL logoAGLAgilon Health, Inc.Current
$115.20$1.92B-19.22-2.11%-1.77%-51.94%—
CNC logoCNCCentene Corp.
$72.59$35.86B24.5519.44%0.75%6.76%—
HUM logoHUMHumana Inc.
$443.43$53.24B43.3910.06%0.81%6.68%0.8%
CVS logoCVSCVS Health Corp.
$85.81$109.49B10.027.85%2.63%14.1%3.11%
ELV logoELVElevance Health Inc.
$433.93$94.11B18.3712.62%2.55%11.56%1.59%
MOH logoMOHMolina Healthcare, Inc.
$221.21$11.55B-237.3511.75%-0.11%-1.17%—

Compare AGL vs Peers

Agilon Health, Inc. (AGL) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs CNC

Most directly comparable listed peer for AGL.

Scale Benchmark

vs UNH

Larger-name benchmark to compare AGL against a more recognizable public peer.

Peer Set

Compare Top 5

vs CNC, HUM, CVS, ELV

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

AGL SEC Filings & Documents

Agilon Health, Inc. (AGL) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Nov 4, 2026·SEC

Material company update

Aug 5, 2026·SEC

Material company update

Jul 22, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 25, 2026·SEC

FY 2025

Feb 25, 2025·SEC

FY 2024

Feb 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Nov 4, 2026·SEC

FY 2026

Aug 5, 2026·SEC

FY 2026

May 6, 2026·SEC

Get notified when AGL posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

AGL Frequently Asked Questions

Agilon Health, Inc. (AGL) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Agilon Health, Inc.'s revenue?

Agilon Health, Inc. (AGL) reported $6.00B in revenue over the trailing twelve months. Revenue was $5.93B in fiscal year 2025. That is 647% more than the $794.4M of fiscal year 2019.

How fast is Agilon Health, Inc. growing?

Agilon Health, Inc. (AGL) grew revenue by 2.0% over the trailing twelve months, compared with the twelve months before.

Is AGL profitable?

No. Agilon Health, Inc. (AGL) reported a net loss of $106.0M over the trailing twelve months.

Dividend & Returns
What is AGL's return on equity?

Agilon Health, Inc. (AGL) had a return on equity (ROE) of -51.9% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is Agilon Health, Inc.'s free cash flow?

Agilon Health, Inc. (AGL) had negative free cash flow of $31.1M over the trailing twelve months.

What if you invested $1,000 in AGL back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →